Search | TVST | ARVO Journals

Showing 1 – 20 of 93

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Glaucoma March 2025

The Association of Social Determinants of Health on Monitoring for Disease Progression Among Patients With Primary Open-Angle Glaucoma

PDF

Kunal Kanwar; Rithambara Ramachandran; Joshua D. Stein; Chris A. Andrews; Azraa S. Chaudhury; Maryam Ige; Xueqing Zhou; Shikha Marwah; Yang Li; Charlesnika T. Evans; Abel N. Kho; Paul J. Bryar; Dustin D. French; on behalf of the Sight Outcomes Research Collaborative (SOURCE) Consortium
TAGS: open-angle glaucoma, optic nerve, disease progression
Trans. Vis. Sci. Tech.. 2025; 14(3):15. https://doi.org/10.1167/tvst.14.3.15

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2024

ENHANCED PHENOTYPE IDENTIFICATION OF COMMON OCULAR DISEASES IN REAL-WORLD DATASETS

Joshua D Stein; Hong Su An; Chris Andrews; Suzann Pershing; Tushar Mungle; Amanda Bicket; Julie M Rosenthal; Amy Zhang; Wei-Shin Lee; Cassie Ludwig; Bethlehem Mekonnen; Tina Hernandez-Boussard

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6511.

ARVO Annual Meeting Abstract June 2024

Measuring the Intersection of Race and Social Determinants of Health on Quality Metrics in Diabetic Eye Care

Azraa S Chaudhury; Maryam Ige; Xueqing Zhou; Shikha Marwah; Chris Andrews; Kunal Kanwar; Charlesnika Evans; Abel N Kho; Joshua D Stein; Paul J Bryar; Dustin D French

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1817.

ARVO Annual Meeting Abstract June 2024

Racial and ethnic disparities in quality of care among patients with newly-diagnosed glaucoma– a multicenter study

Maryam Ige; Azraa S Chaudhury; Yang Li; Joshua D Stein; Chris Andrews; Kunal Kanwar; Xueqing Zhou; Shikha Marwah; Charlesnika Evans; Abel N Kho; Paul J Bryar; Dustin D French

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2814.

ARVO Annual Meeting Abstract June 2024

Decline of visual function and risk of legal blindness with age in patients with RPGR-associated retinal degeneration, a multicenter study

Bela Parekh; Joshua D Stein; Rehbi Abuzaitoun; Kari E Branham; Chris Andrews; Dejan Milentijevic; Divya Narayanan; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3112.

ARVO Annual Meeting Abstract June 2024

RNA Polymerase II Associated Protein 3 ( RPAP3 ), a novel candidate gene for normal-tension glaucoma

William Presley; Sarah Garnai; Bin Guan; Sayoko E Moroi; Natalie Michaels; Bridget Blevins; Brenda Bohnsack; Jill A Rosenfeld; Richard A Lewis; Lindsay Burrage; Shamika Ketkar; Seong H Jeong; Robert Hufnagel; Julia E Richards; Joshua D Stein; Lev Prasov

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4245.

ARVO Annual Meeting Abstract June 2024

The influence of historical eye pressure cutoff on current clinical decision making

Brian Craig Stagg; Ashley Polski; Ben Brintz; Rachel Hess; Kensaku Kawamoto; Felipe Medeiros; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4634.

ARVO Annual Meeting Abstract June 2024

Using artificial intelligence (AI) to identify and characterize RPGR patients in a large electronic health record (EHR) database

Thiran Jayasundera; Kari E. Branham; Dejan Milentijevic; Jinghua He; Alicia K. Campbell; Chris Andrews; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3739.

ARVO Annual Meeting Abstract June 2024

The Impact of Race, Ethnicity, and Sex on Fairness in Artificial Intelligence for Glaucoma

Sophia Y Wang; Rohith Ravindranath; Tina Hernandez-Boussard; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3719.

ARVO Annual Meeting Abstract June 2024

Potential Interaction of Cholesterol with Pigment Dispersion Metabolism

Sanjoy K Bhattacharya; Amar Almobayed; Omar Badla; Shikha Marwah; Krishna Kishor; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3540.

ARVO Annual Meeting Abstract June 2024

The patient journey from early symptoms to initial diagnosis of RPGR -associated retinal disease: Can we shorten time to first diagnosis in a gene therapy era?

Kari E Branham; Chris Andrews; Joshua D Stein; Dejan Milentijevic; Divya Narayanan; Thiran Jayasundera

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):3110.

ARVO Annual Meeting Abstract June 2024

Defining Glaucomatous Vision Loss in Large Datasets Based on the Temporal Relationship of Visual Field and Visual Acuity Loss

Anne Duong; Alice Z Chuang; Robert M Feldman; Angelo Peter Tanna; Donald L Budenz; Pradeep Y Ramulu; Arsham Sheybani; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4824.

ARVO Annual Meeting Abstract June 2023

Understanding the disease course of RPGR -linked vs. RP2 -linked retinitis pigmentosa

Taylor Johnson; Jenna Jensen; Nnana Amakiri; Brian C Stagg; Joshua D Stein; Barbara Wirostko

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4667.

ARVO Annual Meeting Abstract June 2023

Leveraging the Sight Outcomes Research Collaborative (SOURCE) Repository to Identify Patients with RPGR-Related Retinitis Pigmentosa

Nnana Amakiri; Kari Branham; K. Thiran Jayasundera; Chris A. Andrews; Dejan Milentijevic; Divya Narayanan; Taylor Johnson; Jenna Jensen; Barbara M Wirostko; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4664.

ARVO Annual Meeting Abstract June 2023

Bayesian modeling to predict long-term visual field test variability in patients with glaucoma

Brian C Stagg; Ben Brintz; Joshua D Stein; Rachel Hess; Kensaku Kawamoto; Alessandro Jammal; Felipe A Medeiros

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5113.

ARVO Annual Meeting Abstract June 2023

Machine learning approaches for predicting glaucoma progression in a large multicenter electronic health records consortium: the Sight Outcomes Research Collaborative (SOURCE)

Sophia Y Wang; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):357.

ARVO Annual Meeting Abstract June 2023

Medical Comorbidities and Severe Visual Impairment in Real-World Patients With Inherited Retinal Diseases

Kari E Branham; K. Thiran Jayasundera; Dejan Milentijevic; Jinghua He; Alicia Campbell; Chris A. Andrews; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5440.

ARVO Annual Meeting Abstract June 2023

Presence of Medical Conditions that Can Impair Patients with Glaucoma from Administering Topical Glaucoma Medications – A Study using the Sight Outcomes Research Collaborative (SOURCE) Repository

Jaqueline Stoutin; An Hong Su; Kennedy Depperschmidt; Matthew Callewaert; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):382.

ARVO Annual Meeting Abstract June 2023

Use of Natural Language Processing to Accurately Identify Cataracts and Other Lens Pathology in Electronic Health Record Data – A Study Using the Sight Outcomes Research Collaborative (SOURCE) Repository

Joshua D Stein; Yunshu Zhou; Chris A. Andrews; Victoria Addis; Jill Bixler; Nathan Grove; Judy E Kim; Brian McMillian; Saleha Munir; Jeffrey Schultz; Brian C Stagg; Sophia Wang; Fasika Woreta

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1199.

ARVO Annual Meeting Abstract June 2023

Prevalence of Dry Eyes in Patients with Common Neurological, Musculoskeletal, and Rheumatological Conditions – A Study Using the Sight Outcomes Research Collaborative (SOURCE) Repository

Alex Valentine; Kennedy Depperschmidt; Matthew Callewaert; An Hong Su; Joshua D Stein

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2879.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Association of Social Determinants of Health on Monitoring for Disease Progression Among Patients With Primary Open-Angle Glaucoma

ENHANCED PHENOTYPE IDENTIFICATION OF COMMON OCULAR DISEASES IN REAL-WORLD DATASETS

Measuring the Intersection of Race and Social Determinants of Health on Quality Metrics in Diabetic Eye Care

Racial and ethnic disparities in quality of care among patients with newly-diagnosed glaucoma– a multicenter study

Decline of visual function and risk of legal blindness with age in patients with RPGR-associated retinal degeneration, a multicenter study

RNA Polymerase II Associated Protein 3 ( RPAP3 ), a novel candidate gene for normal-tension glaucoma

The influence of historical eye pressure cutoff on current clinical decision making

Using artificial intelligence (AI) to identify and characterize RPGR patients in a large electronic health record (EHR) database

The Impact of Race, Ethnicity, and Sex on Fairness in Artificial Intelligence for Glaucoma

Potential Interaction of Cholesterol with Pigment Dispersion Metabolism

The patient journey from early symptoms to initial diagnosis of RPGR -associated retinal disease: Can we shorten time to first diagnosis in a gene therapy era?

Defining Glaucomatous Vision Loss in Large Datasets Based on the Temporal Relationship of Visual Field and Visual Acuity Loss

Understanding the disease course of RPGR -linked vs. RP2 -linked retinitis pigmentosa

Leveraging the Sight Outcomes Research Collaborative (SOURCE) Repository to Identify Patients with RPGR-Related Retinitis Pigmentosa

Bayesian modeling to predict long-term visual field test variability in patients with glaucoma

Machine learning approaches for predicting glaucoma progression in a large multicenter electronic health records consortium: the Sight Outcomes Research Collaborative (SOURCE)

Medical Comorbidities and Severe Visual Impairment in Real-World Patients With Inherited Retinal Diseases

Presence of Medical Conditions that Can Impair Patients with Glaucoma from Administering Topical Glaucoma Medications – A Study using the Sight Outcomes Research Collaborative (SOURCE) Repository

Use of Natural Language Processing to Accurately Identify Cataracts and Other Lens Pathology in Electronic Health Record Data – A Study Using the Sight Outcomes Research Collaborative (SOURCE) Repository

Prevalence of Dry Eyes in Patients with Common Neurological, Musculoskeletal, and Rheumatological Conditions – A Study Using the Sight Outcomes Research Collaborative (SOURCE) Repository

To View More...

You must be signed into an individual account to use this feature.